Zafrens Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 15

Zafrens General Information

Description

Developer of life sciences products designed to generate insights at the interface of biology and engineering. The company's technology utilizes nanofabrication, messenger ribonucleic acid sequencing, multi-omics analysis, and longitudinal imaging, enabling the medical industry to map molecular states of single cells directly to their functional manifestations in drug discovery.

Contact Information

Website
www.zafrens.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5890 Pacific Center Boulevard
  • Suite 200
  • San Diego, CA 92121
  • United States
+1 (215)
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Discovery Tools (Healthcare)
Corporate Office
  • 5890 Pacific Center Boulevard
  • Suite 200
  • San Diego, CA 92121
  • United States
+1 (215)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zafrens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Generating Revenue
3. Early Stage VC (Series A) 03-Nov-2026 Completed Generating Revenue
2. Seed Round 13-Jan-2022 $6M $9M Completed Startup
1. Seed Round $3M $3M Completed Startup
To view Zafrens’s complete valuation and funding history, request access »

Zafrens Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
Seed-1 178,372 $0.000100 $0.9 $0.9 1x $0.9 0.41%
Seed 3,715,171 $0.000100 $1.61 $1.61 1x $1.61 8.61%
To view Zafrens’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Zafrens Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of life sciences products designed to generate insights at the interface of biology and engineering. The compa
Biotechnology
San Diego, CA
31 As of 2026

Newark, CA
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zafrens Competitors (47)

One of Zafrens’s 47 competitors is ATUM (Biotechnology), a Formerly VC-backed company based in Newark, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ATUM (Biotechnology) Formerly VC-backed Newark, CA
Deep Genomics Venture Capital-Backed Toronto, Canada
Integrated DNA Technologies Formerly PE-Backed Coralville, IA
Twist Bioscience Formerly VC-backed South San Francisco, CA
Valo Venture Capital-Backed Lexington, MA
You’re viewing 5 of 47 competitors. Get the full list »

Zafrens Patents

Zafrens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026072889-A2 Reversible transfer devices and uses thereof Pending 26-Sep-2024
WO-2026072889-A3 Reversible transfer devices and uses thereof Pending 26-Sep-2024
WO-2025159784-A1 Capture beads for use in assays Pending 23-Jan-2024
WO-2025160235-A1 Capture beads for use in assays Pending 23-Jan-2024
US-20250236863-A1 High throughput assays for identifying the biological response of a cell Pending 23-Jan-2024 C12N15/1065
To view Zafrens’s complete patent history, request access »

Zafrens Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zafrens Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Brain Venture Capital Minority
imec.xpand Venture Capital Minority
KOFA Healthcare Venture Capital Minority
Mitsui Chemicals Corporation Minority
Prime Movers Lab Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Zafrens FAQs

  • When was Zafrens founded?

    Zafrens was founded in 2021.

  • Where is Zafrens headquartered?

    Zafrens is headquartered in San Diego, CA.

  • What is the size of Zafrens?

    Zafrens has 31 total employees.

  • What industry is Zafrens in?

    Zafrens’s primary industry is Biotechnology.

  • Is Zafrens a private or public company?

    Zafrens is a Private company.

  • What is Zafrens’s current revenue?

    The current revenue for Zafrens is .

  • How much funding has Zafrens raised over time?

    Zafrens has raised $38M.

  • Who are Zafrens’s investors?

    Global Brain, imec.xpand, KOFA Healthcare, Mitsui Chemicals, and Prime Movers Lab are 5 of 15 investors who have invested in Zafrens.

  • Who are Zafrens’s competitors?

    ATUM (Biotechnology), Deep Genomics, Integrated DNA Technologies, Twist Bioscience, and Valo are some of the 47 competitors of Zafrens.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process